Harbour BioMed
Pre-clinicalHarbour BioMed (HBM Holdings) is a global biopharmaceutical company committed to the r&d and commercialization of novel antibody therapeutics in oncology and immunological diseases.
Founded
2016
Focus
AntibodiesBiologics
About
Harbour BioMed (HBM Holdings) is a global biopharmaceutical company committed to the r&d and commercialization of novel antibody therapeutics in oncology and immunological diseases.
Funding History
3Total raised: $387M
Series C$210MCBC GroupJan 15, 2022
Series B$102MHBM Healthcare InvestmentsMar 15, 2021
Series A$75MOrbiMedJun 15, 2020
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile